封面
市場調查報告書
商品編碼
2050912

大麻二酚市場:依原料、產品類型、應用、通路和地區分類

Cannabidiol Market, By Source Type, By Product, By Application, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

據估計,2026年大麻二酚(CBD)市值為110.4億美元,預計2033年將達到325.4億美元。預計從2026年到2033年,其複合年成長率將達到16.7%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 110.4億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 16.70% 2033年市場規模預測: 325.4億美元

大麻二酚 (CBD) 是大麻植物(如工業大麻和娛樂大麻)中的主要大麻素之一。它具有多種潛在的醫療益處和治療效果,且不具有四氫大麻Delta(THC) 的精神活性作用。人們對 CBD 在治療失眠、慢性疼痛、焦慮和癲癇等疾病方面的療效認知不斷提高,這可能會加速含 CBD 產品的普及。此外,一些國家醫用大麻合法化的進程也為 CBD 生產商和銷售商創造了新的商機。目前正在進行多項研究以檢驗CBD 的有效性和安全性,這有望在未來進一步擴大 CBD 產品的商業化範圍。

市場動態

醫用大麻合法化的推進以及大麻衍生產品的日益普及有望推動全球大麻二酚(CBD)市場的成長。企業加大對大麻研究的投資以及新產品的推出也將促進市場成長。此外,文明病、精神疾病和慢性病的日益普遍也推動了對治療性CBD產品的需求。然而,某些監管規定可能會阻礙市場成長。此外,缺乏關於療效和安全性的臨床試驗數據也可能是阻礙市場成長的因素之一。另一方面,CBD在食品飲料和個人保健產品領域的應用日益廣泛,也可能為市場擴張帶來機會。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數創建了全球大麻二酚市場主要公司的概況:公司亮點、產品系列、主要特徵、財務表現和策略。
  • 透過利用本報告中的見解,企業負責人和經營團隊將能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球大麻二酚市場報告面向產業內的各種相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過分析全球大麻二酚市場時所使用的各種策略矩陣,相關人員將能夠更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管趨勢
  • 收購與合作趨勢
  • 資金籌措及投資
  • PEST分析
  • 波特的分析

第4章 全球大麻二酚市場:依來源分類,2021-2033年

  • 概述
  • 大麻

第5章 全球大麻二酚市場:依產品分類,2021-2033年

  • 概述
  • 酊劑
  • 栓劑
  • 經皮吸收貼劑
  • 電子煙油
  • 隔離群
  • 乳霜和滾珠
  • 膠囊
  • 藥片
  • 其他

第6章 全球大麻二酚市場:依應用領域分類,2021-2033年

  • 概述
  • 醫學領域

第7章 全球大麻二酚市場:依通路分類,2021-2033年

  • 概述
  • 醫院藥房
  • 網路商店
  • 零售店

第8章 全球大麻二酚市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第9章 競爭情勢

  • 公司簡介
    • ENDOCA
    • Cannoid LLC
    • Medical Marijuana Inc.
    • Folium Biosciences
    • Elixinol
    • NuLeaf Naturals LLC
    • Isodiol International Inc.
    • Pharmahemp doo
    • Aurora Cannabis Inc.
    • CV Sciences
    • Medterra CBD
    • Canopy Growth Corporation
    • Aphria, Inc.
    • GW Pharmaceuticals Plc
    • Organigram Holding Inc.

第10章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第11章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI4613

Cannabidiol Market is estimated to be valued at USD 11.04 Bn in 2026 and is expected to reach USD 32.54 Bn by 2033, growing at a compound annual growth rate (CAGR) of 16.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 11.04 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 16.70% 2033 Value Projection: USD 32.54 Bn

Cannabidiol or CBD is one of the primary cannabinoids found in cannabis plants like hemp and marijuana. It has several potential medical benefits and therapeutic effects without the psychotropic effects of THC, Delta-9-tetrahydrocannabinol. Rising awareness about the therapeutic properties of CBD for conditions like insomnia, chronic pain, anxiety, and epilepsy can boost adoption of cannabidiol-infused products. Moreover, legalization of cannabis in several countries for medical use offer new opportunities for cannabidiol manufacturers and vendors. Various studies examining the efficacy and safety of CBD are underway, which can further augment the commercialization scope of CBD products in the future.

Market Dynamics

Rising legalization of medical cannabis and growing adoption of cannabis-based products can drive the global cannabidiol market growth. Increasing investments by companies in cannabis research and new product launches can drive the market growth. Furthermore, rising prevalence of lifestyle diseases, mental health disorders, and chronic conditions boosts demand for therapeutic CBD products. However, certain regulations can hamper the market growth. Lack of clinical trials data on efficacy and safety can also hamper the market growth. Meanwhile, growing adoption in food & beverages, and personal care products can offer opportunities for market expansion.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global cannabidiol market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include CV Sciences, Inc., Isodiol, Medical Marijuana Inc., Aurora Cannabis, ENDOCA, Elixinol and GAIA Botanicals LLC.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global cannabidiol market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cannabidiol market.

Market Segmentation

  • Source Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Hemp
  • Marijuana
  • Product Insights (Revenue, USD Bn, 2021 - 2033)
  • Oil
  • Tinctures
  • Suppository
  • Transdermal patches
  • Vape Oil
  • Isolates
  • Creams and Roll-on
  • Capsules
  • Tablet
  • Others
  • Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Medical
    • Chronic Pain
    • Mental Disorders
    • Cancer
    • Others
  • Personal Use
  • Pharmaceuticals
  • Wellness
    • Food & Beverages
    • Personal Care & Cosmetics
    • Nutraceuticals
    • Others
  • Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospital Pharmacies
  • Online Stores
  • Retail Stores
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • ENDOCA
  • Cannoid LLC
  • Medical Marijuana Inc.
  • Folium Biosciences
  • Elixinol
  • NuLeaf Naturals LLC
  • Isodiol International Inc.
  • Pharmahemp d.o.o.
  • Aurora Cannabis Inc.
  • CV Sciences
  • Medterra CBD
  • Canopy Growth Corporation
  • Aphria, Inc.
  • GW Pharmaceuticals Plc
  • Organigram Holding Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Source Type
    • Market Snapshot, By Product
    • Market Snapshot, By Application
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Cannabidiol Market, By Source Type, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hemp
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Marijuana
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Cannabidiol Market, By Product, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Oil
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Tinctures
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Suppository
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Transdermal patches
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Vape Oil
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Isolates
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Creams and Roll-on
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Capsules
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Tablet
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Cannabidiol Market, By Application, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Medical
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
      • Chronic Pain
      • Mental Disorders
      • Cancer
      • Others
    • Personal Use
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Pharmaceuticals
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Wellness
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
        • Food & Beverages
        • Personal Care & Cosmetics
        • Nutraceuticals
      • Others

7. Global Cannabidiol Market, By Distribution Channel, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Online Stores
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Retail Stores
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Cannabidiol Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • ENDOCA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cannoid LLC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Medical Marijuana Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Folium Biosciences
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Elixinol
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • NuLeaf Naturals LLC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Isodiol International Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pharmahemp d.o.o.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Aurora Cannabis Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • CV Sciences
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Medterra CBD
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Canopy Growth Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Aphria, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GW Pharmaceuticals Plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Organigram Holding Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact